Status:
UNKNOWN
Clopidogrel Resistance in Stroke Patients From Different Ethnicities
Lead Sponsor:
Ziv Hospital
Conditions:
Clopidogrel, Poor Metabolism of
Ischemic Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Clopidogrel is an anti-platelet agent used to inhibit blood clots. Variation in response to clopidogrel has been reported among different population and may lead to reoccurring ischemic events. The ai...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent and to be compliant with protocol assessments.
- Ages 18 and above inclusive
- Both genders eligible for the study
- Diagnosis of ischemic cerebrovascular event
Exclusion
- Pregnant patients will be excluded
- Ages below 18
- Patients not able to provide informed consent
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03806894
Start Date
October 1 2019
End Date
December 1 2020
Last Update
July 10 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.